The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J06 | Immune sera and immunoglobulins | |
| 3 | J06B | Immunoglobulins | |
| 4 | J06BA | Immunoglobulins, normal human | |
| 5 | J06BA02 | Immunoglobulins, normal human, for intravascular adm. |
| Active Ingredient | Description | |
|---|---|---|
| Immunoglobulins, normal human, IV |
Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| FLEBOGAMMA DIF Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| GAMMAPLEX Solution for infusion | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| GAMUNEX Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| GAMUNEX-C Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| INTRAGAM Solution for infusion | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC | |
| KIOVIG Solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC | |
| PANZYGA Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
